Insmed Incorporated (BST:IM8N)

Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of EUR 26.11 billion. The enterprise value is 25.16 billion.

Market Cap	26.11B
Enterprise Value	25.16B

Important Dates

The next estimated earnings date is Thursday, October 30, 2025.

Earnings Date	Oct 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	211.37M
Shares Outstanding	n/a
Shares Change (YoY)	+22.38%
Shares Change (QoQ)	+4.67%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	190.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	77.03
PB Ratio	24.54
P/TBV Ratio	28.32
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-28.57
EV / Sales	74.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-34.02

Financial Position

The company has a current ratio of 6.68, with a Debt / Equity ratio of 0.59.

Current Ratio	6.68
Quick Ratio	6.13
Debt / Equity	0.59
Debt / EBITDA	n/a
Debt / FCF	-0.85
Interest Coverage	-10.49

Financial Efficiency

Return on equity (ROE) is -160.54% and return on invested capital (ROIC) is -34.07%.

Return on Equity (ROE)	-160.54%
Return on Assets (ROA)	-27.03%
Return on Invested Capital (ROIC)	-34.07%
Return on Capital Employed (ROCE)	-42.79%
Revenue Per Employee	266,708
Profits Per Employee	-692,952
Employee Count	1,271
Asset Turnover	0.19
Inventory Turnover	0.98

Taxes

In the past 12 months, Insmed has paid 3.78 million in taxes.

Income Tax	3.78M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +79.56% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+79.56%
50-Day Moving Average	88.37
200-Day Moving Average	72.71
Relative Strength Index (RSI)	89.44
Average Volume (20 Days)	12

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.71

Income Statement

In the last 12 months, Insmed had revenue of EUR 338.99 million and -880.74 million in losses. Loss per share was -4.87.

Revenue	338.99M
Gross Profit	256.67M
Operating Income	-789.92M
Pretax Income	-876.96M
Net Income	-880.74M
EBITDA	-781.22M
EBIT	-789.92M
Loss Per Share	-4.87

Balance Sheet

The company has 1.58 billion in cash and 629.29 million in debt, giving a net cash position of 951.74 million.

Cash & Cash Equivalents	1.58B
Total Debt	629.29M
Net Cash	951.74M
Net Cash Per Share	n/a
Equity (Book Value)	1.06B
Book Value Per Share	5.04
Working Capital	1.51B

Cash Flow

In the last 12 months, operating cash flow was -719.14 million and capital expenditures -20.45 million, giving a free cash flow of -739.58 million.

Operating Cash Flow	-719.14M
Capital Expenditures	-20.45M
Free Cash Flow	-739.58M
FCF Per Share	n/a

Margins

Gross margin is 75.72%, with operating and profit margins of -233.02% and -259.82%.

Gross Margin	75.72%
Operating Margin	-233.02%
Pretax Margin	-258.70%
Profit Margin	-259.82%
EBITDA Margin	-230.46%
EBIT Margin	-233.02%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.38%
Shareholder Yield	n/a
Earnings Yield	-3.37%
FCF Yield	-2.83%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of 3.44 and a Piotroski F-Score of 3.

Altman Z-Score	3.44
Piotroski F-Score	3